Page 27 - Phase 3 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Trials of homegrown COVID-19 vaccine show positive signs Chia sẻ | FaceBookTwitter Email Copy Link Copy link bài viết thành công  05/06/2021    14:28 GMT+7 The clinical trials of Vietnamese COVID-19 vaccine candidate Nano Covax are set to enter Phase 3 this month with the optimal dosage of 25mcg, aiming to further test the safety and efficacy of the vaccine in humans before mass production begins. Doctor prepares to inject Nano Covax COVID-19 vaccine on a volunteer. (Photo: VNA) ...

The clinical trials of Vietnamese COVID-19 vaccine candidate Nano Covax are set to enter Phase 3 this month with the optimal dosage of 25mcg, aiming to further test the safety and efficacy of the vaccine in humans before mass production begins.

The EMPHATHY clinical trial will enroll patients with COVID-19 to test the drug’s effectiveness in preventing worsening of symptoms and hospitalization. Novartis and Molecular Partners have announced the start of their EMPATHY Phase II/III study to explore the use of its DARPin (designed ankyrin repeat proteins) therapeutic candidate ensovibep (MP0420) for the treatment of COVID-19. Novartis reportedly will run the trial program, with Molecular Partners serving as sponsor. The EMPATHY clinical trial program is intended to investigate the safety and efficacy of en...

New Delhi [India], May 28 (ANI): India achieved a significant landmark in its ongoing COVID-19 vaccination drive as the cumulative number of coronavirus vaccines administered cross 21 crores on Saturday, according to the Union Ministry of Health and Family Welfare (MoHFW).

New Delhi [India], May 28 (ANI): India achieved a significant landmark in its ongoing COVID-19 vaccination drive as the cumulative number of coronavirus vaccines administered reached the 20.86 crore mark on Friday, according to the Union Ministry of Health and Family Welfare (MoHFW).